Cytek Biosciences Reports Second Quarter 2026 Financial Results
Globe Newswire•05/08/2026•16:05 ET
0
Whiz Insights
FREMONT, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second quarter ended June 30, 2026.
Recent Highlights * Total revenue for the second quarter of 2026 was $48.1 million, representing a 6% increase compared to the second quarter of 2025
Get started
Create a free account to read the full story.